KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD

Khiron Life Sciences Corp.

2300-550 Burrard Street
Vancouver V6C 2B5
Canada
705-527-3564
http://www.khiron.ca

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Alvaro Francisco TorresFounder, CEO & Director425kN/A1979
Mr. Chris NaprawaPres1.69MN/A1970
Mr. Darren CollinsCFO & Corp. Sec.205kN/A1984
Mr. Andres GalofreCo-founder & VP of Bus. Devel.sN/AN/A1982
Mr. Matt MurphyVP of ComplianceN/AN/A1961
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America. It operates through four business units: Pharma Medical, Khiron Clinics, Wellness, and Dixie JV. The company focuses on the cultivation, production, distribution, and export of THC (tetrahydrocannabinol) and CBD (cannabidiol) medical cannabis. It also develops CBD-based cosmeceutical products for women and men's categories; and operates the company owned medical clinics. In addition, the company develops cannabis products in the food and beverage, supplements, and pets categories. The company was founded in 2017 and is headquartered in Vancouver, Canada.

Corporate Governance

Khiron Life Sciences Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.